AUS
NZ
UK
CA
USA
IND
Highlights
- The NZ govt signs a deal for buying a new drug for COVID-19 treatment.
- TruScreen Group discusses its key milestones related to its technology and growth strategy.
- Fisher & Paykel Healthcare Corporation to declare interim results this month.
A good healthcare system assures a healthy economy and workforce. A nation can thrive and prosper only when its population is strong and healthy and have a positive outlook towards the future.
New Zealand boasts a well-established and robust healthcare system. Recently, Pharmac, the Government agency, has signed an agreement with the pharmaceutical supplier, Roche to buy another drug, Ronapreve for COVID-19 treatment.
The said medicine is currently being assessed by Medsafe and is expected to arrive in the country by Christmas.
That said, let us discuss the five NZX-listed healthcare stocks worth looking at in 2022.
Image source: © 2021 Kalkine Media New Zealand Ltd, data source- EODHD/Others
TruScreen Group Limited (NZX:TRU)
TruScreen Group Limited is famous for making cancer screening devices. Recently, the Company has disclosed achieving key milestones related to women’s health care technology as well as its overseas growth strategy.
Related Read: TruScreen (NZX:TRU):How effective is the Company’s cancer screening technology?
Also, TRU has completed the validation of a Firmware update, which will enhance its device's cyber security framework.
The Company has considerably expanded in the Chinese market and has also gained access throughout Central and Eastern Europe.
It is noted that TruScreen would release its interim performance towards the end of this month.
On 1 November, at the closing bell, TruScreen Group was flat at NZ$0.085.
Radius Residential Care Limited (NZX:RAD)
Radius Residential Care Limited is a well-known residential, rest homes, and respite care facility across the country. The Company has announced acquiring Invercargill-based retirement village, Clare House.
The said acquisition involves a purchase price of NZ$14.5 million and would greatly attribute to uplifting RAD’s earnings and revenue.
On 1 November, at the closing bell, Radius Residential Care gained by 1.92% at NZ$0.530.
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH)
Globally acclaimed designer, manufacturer, and supplier of respiratory care products is Fisher & Paykel Healthcare Corporation Limited.
Interesting Read: Fisher & Paykel (NZX:FPH): What is its latest product launch all about?
On 25 November, FPH will publish its half-year results, followed by a conference call to discuss the said performance.
On 1 November, at the closing bell, Fisher & Paykel Healthcare Corporation dropped by 0.48% at NZ$31.060.
Pacific Edge Limited (NZX:PEB)
Pacific Edge Limited develops and markets diagnostic and prognostic tools for early cancer detection and its management. A few days back, PEB revealed the appointment of its new Chief Executive Officer, Dr Peter Meintjes.
He will join the Company in January 2022 and will bring on Board this vast expertise related to global diagnostics, and biotechnology.
On 1 November, at the closing bell, Pacific Edge fell by 1.36% at NZ$1.450.
Do Read: Pacific (NZX:PEB): How is the Company doing post ASX listing?
Oceania Healthcare Limited (NZX:OCA)
Oceania Healthcare Limited is New Zealand’s leading provider of rest homes, hospitals, and dementia care for the aged population. Today, the Company has declared a change in its registered office, address, and also its contact number.
OCA has now shifted its base to Auckland’s Queen Street.
Also Read: Are these 10 best healthcare companies on the NZX?
On 1 November, at the closing bell, Oceania Healthcare declined by 0.71% at NZ$1.390.
Bottom Line
The NZ government makes sure that its residents are equipped with top-quality healthcare facilities and have access to new COVID-19-related medicines.